INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2013

A 4% isoflavone vaginal gel relieved vaginal atrophy symptoms and improved vaginal cell maturation values in postmenopausal women over 12 weeks.

Ninety postmenopausal women were randomized to receive 4% isoflavone vaginal gel (1 g/day), placebo gel, or conjugated equine estrogen cream (0.3 mg/day) for 12 weeks. Isoflavone vaginal gel was effective for relieving vaginal dryness and dyspareunia symptoms and increased intermediate and superficial cells, showing results similar to conjugated equine estrogens and superior to placebo. No changes in endometrial thickness, serum FSH, or estradiol levels were observed at the study endpoint.

Study type
Double-blind, randomized, placebo-controlled clinical trial
Who was studied
90 postmenopausal women
What was measured
Vaginal atrophy symptoms, vaginal cytology maturation value, and endometrial safety

THE PAPER

Effective treatment of vaginal atrophy with isoflavone vaginal gel.

Lima SM, Yamada SS, Reis BF, Postigo S, Galvão da Silva MA, Aoki T. Maturitas, 2013.

PubMed 23312487 ↗DOI 10.1016/j.maturitas.2012.11.012 ↗

Healthy aging & longevityOther health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.